nebulized glutathione for parkinson' Parkinson's Disease - 2025 - Movement Disorders Parkinson's Disease Treatment | IV
Description
doi: 10.1038/ni1229
In darbepoetin alfa, enhanced half-life is also attributed to its increased sialic acid content, making clearance mediated by asialoglycoprotein receptors (found in liver cells) less favorable 66
Currently, anti-inflammatory and antioxidant strategies remain the cornerstone of interventions targeting the pathological remodeling of the local microenvironment
Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases
